Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
FLS contributed with study conception, study design, data analysis, data interpretation, critical manuscript revision and final manuscript approval
Proven weight loss, the affordable way Up to 15-20% weight loss with Wegovy and Zepbound* Affordable GLP-1s, delivered fast** Covered by top insurance plans Proven weight loss, the affordable way Up to 15-20% weight loss with Wegovy and Zepbound* Affordable GLP-1s, delivered fast** Covered by top insurance plans *In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20% respectively, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
Therefore, future research is strongly encouraged, particularly if access to a larger sample size dataset is granted, and ensuring that the exposure and outcome datasets are mutually independent
While evidence supports some benefits, routine use should be guided by healthcare professionals to maximize safety and efficacy
[DOI] [PubMed] [Google Scholar] 71.Petersen JA, Wilm BJ, von Meyenburg J, Schubert M, Seifert B, Najafi Y, et al
US$ 20.84
US$ 27.47
US$ 20.41
US$ 27.07
US$ 23.20
US$ 20.83
US$ 23.97
US$ 21.30
US$ 24.43
